|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 137.68 USD | -2.30% |
|
+6.51% | +58.40% |
| Market Cap | 9.06B 7.94B 7.34B 6.75B 12.74B 874B 12.95B 87.79B 34.41B 428B 34.03B 33.29B 1,473B | P/E 2026 * |
35.7x | P/E 2027 * | -123x |
|---|---|---|---|---|---|
| Enterprise Value | 8.49B 7.44B 6.88B 6.32B 11.93B 819B 12.13B 82.23B 32.23B 400B 31.87B 31.18B 1,380B | EV / Sales 2026 * |
16.6x | EV / Sales 2027 * | 52.2x |
| Free-Float |
97.28% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Protagonist Therapeutics, Inc.
| 1 day | -1.91% | ||
| 1 week | +6.51% | ||
| Current month | +12.86% | ||
| 1 month | +20.27% | ||
| 3 months | +31.17% | ||
| 6 months | +65.84% | ||
| Current year | +58.40% |
| 1 week | 126.97 |  | 143.29 |
| 1 month | 113.24 | | 143.29 |
| Current year | 77 | | 143.29 |
| 1 year | 50.48 | | 143.29 |
| 3 years | 13.72 | | 143.29 |
| 5 years | 6.91 | | 143.29 |
| 10 years | 4.47 | | 143.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 69 | 01/12/2008 |
Asif Ali
DFI | Director of Finance/CFO | 52 | 18/04/2022 |
Venkat Thalladi
CTO | Chief Tech/Sci/R&D Officer | - | 01/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Dinesh Patel
BRD | Director/Board Member | 69 | 01/12/2008 |
Harold Selick
CHM | Chairman | 71 | 19/03/2014 |
William Waddill
BRD | Director/Board Member | 69 | 01/07/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/23/26 A | Fiscal year | Director | 27,000 | 0.0420% | ||
| 6/10/26 A | Fiscal year | Director | 27,000 | 0.0420% | ||
| 5/29/26 A | Fiscal year | Director | 27,000 | 0.0420% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.30% | +6.51% | +150.53% | +595.20% | 9.06B | |
| -0.49% | -4.01% | +0.61% | +2.28% | 49.18B | |
| -1.50% | -0.13% | +378.16% | +584.97% | 39.58B | |
| -0.49% | +2.77% | +7.01% | +61.95% | 34.69B | |
| -0.54% | -0.97% | +29.30% | -9.20% | 34.42B | |
| -1.82% | -1.48% | +0.52% | +32.02% | 27.11B | |
| -2.49% | -4.12% | - | - | 16.21B | |
| -0.89% | +0.74% | +72.92% | +116.33% | 15.36B | |
| +1.17% | +2.30% | +15.46% | +18.26% | 14.05B | |
| -2.15% | +0.28% | +19.29% | -32.68% | 13.02B | |
| Average | -0.94% | +0.57% | +74.87% | +152.13% | 25.27B | |
| Weighted average by Cap. | -0.79% | -0.11% | +81.25% | +139.45% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 512M 448M 415M 381M 719M 49.34B 731M 4.96B 1.94B 24.14B 1.92B 1.88B 83.17B | 163M 143M 132M 121M 229M 15.69B 232M 1.58B 618M 7.68B 611M 598M 26.45B |
| Net income | 249M 218M 201M 185M 349M 23.97B 355M 2.41B 944M 11.73B 933M 913M 40.41B | -82.92M -72.68M -67.18M -61.79M -117M -8B -118M -803M -315M -3.91B -311M -305M -13.48B |
| Net Debt | -574M -503M -465M -428M -807M -55.34B -820M -5.56B -2.18B -27.08B -2.16B -2.11B -93.3B | -565M -495M -458M -421M -794M -54.46B -807M -5.47B -2.14B -26.65B -2.12B -2.07B -91.8B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/07/26 | $138.11 | -1.99% | 279,235 |
| 17/07/26 | $140.91 | +6.73% | 519,116 |
| 16/07/26 | $132.02 | -2.54% | 602,064 |
| 15/07/26 | $135.46 | +3.19% | 836,109 |
| 14/07/26 | $131.27 | +1.06% | 564,974 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PTGX Stock
Select your edition
All financial news and data tailored to specific country editions
